Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab
Author:
Affiliation:
1. University of Texas Southwestern Medical Center; Dallas
2. Bristol-Myers Squibb; Princeton New Jersey
3. University of Colorado; Denver
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.39714/fullpdf
Reference19 articles.
1. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2016
2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014
3. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score;Aletaha;Arthritis Res Ther,2005
4. A Simplified Disease Activity Index for rheumatoid arthritis for use in clinical practice;Smolen;Rheumatology (Oxford),2003
5. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis;Prevoo;Arthritis Rheum,1995
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update;Annals of the Rheumatic Diseases;2022-11-10
2. Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis;RMD Open;2022-09
3. Synovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients;Journal of Clinical Medicine;2021-10-28
4. Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects;RMD Open;2021-06
5. Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers;Expert Review of Clinical Immunology;2021-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3